MFAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.435000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.517400E-01
Normal-vs-Stage2
5.431400E-01
Normal-vs-Stage3
2.806000E-01
Normal-vs-Stage4
7.113800E-01
Stage1-vs-Stage2
2.891000E-01
Stage1-vs-Stage3
1.172810E-01
Stage1-vs-Stage4
5.203600E-01
Stage2-vs-Stage3
3.003000E-01
Stage2-vs-Stage4
8.270800E-01
Stage3-vs-Stage4
4.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.557400E-01
Normal-vs-AfricanAmerican
6.682000E-01
Normal-vs-Asian
2.159200E-01
Caucasian-vs-AfricanAmerican
6.950000E-01
Caucasian-vs-Asian
2.287000E-01
AfricanAmerican-vs-Asian
2.028400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.356800E-01
Normal-vs-Female
6.823600E-01
Male-vs-Female
1.548830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.016400E-01
Normal-vs-Age(41-60Yrs)
9.697200E-01
Normal-vs-Age(61-80Yrs)
3.730000E-01
Normal-vs-Age(81-100Yrs)
1.305040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.959000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.047000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.045700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.230300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.655900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.986350E-01
Normal-vs-Daily Drinker
4.419200E-01
Normal-vs-Weekly Drinker
3.908400E-01
Normal-vs-Occasional Drinker
8.461200E-01
Normal-vs-Social Drinker
5.360800E-01
Non Drinker-vs-Daily Drinker
4.401600E-01
Non Drinker-vs-Weekly Drinker
7.033800E-01
Non Drinker-vs-Occasional Drinker
5.049900E-02
Non Drinker-vs-Social Drinker
1.470040E-01
Daily Drinker-vs-Weekly Drinker
8.011000E-01
Daily Drinker-vs-Occasional Drinker
2.800200E-01
Daily Drinker-vs-Social Drinker
5.520800E-01
Weekly Drinker-vs-Occasional Drinker
2.379000E-01
Weekly Drinker-vs-Social Drinker
4.236200E-01
Occasional Drinker-vs-Social Drinker
5.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.827400E-01
Normal-vs-Grade 2
9.216400E-02
Normal-vs-Grade 3
5.235800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.401200E-01
Grade 1-vs-Grade 3
1.045350E-01
Grade 1-vs-Grade 4
2.827400E-01
Grade 2-vs-Grade 3
2.079400E-01
Grade 2-vs-Grade 4
9.216400E-02
Grade 3-vs-Grade 4
5.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.610600E-01
Normal-vs-NonDiabetic
5.010400E-01
Diabetic-vs-NonDiabetic
2.475400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.814000E-01
Normal-vs-NoPancreatitis
4.716200E-01
Pancreatitis-vs-NoPancreatitis
1.784970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.600600E-01
Normal-vs-N1
6.095000E-01
N0-vs-N1
5.240400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.895600E-01
Normal-vs-TP53-NonMutant
6.108800E-01
TP53-Mutant-vs-TP53-NonMutant
1.737600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
